Wednesday, August 24, 2016

Numbers don't lie: why Monsanto may be facing its final days...

Share prices — plummeting. Royalties — cut. Consumer opinion — in the toilet. Governments — fed up. Monsanto’s earnings represent the writing on the wall, but the company’s glory days are nearing an end for many reasons ranging from farmer and consumer resistance to government crackdowns on GMO products and even Monsanto’s best-selling chemical product, glyphosate. Monsanto’s days are about as numbered as a fruit fly’s.

If we were to ascertain Monsanto’s financial health by their stock price alone, you could safely say that they are suffering. The company recently slashed its 2016 earnings forecast from the $5.10-$5.60 per share it had forecast in December, to $4.40-$5.10, claiming that the reduction was due to a lagging strength in the U.S. dollar — but there’s much more to the picture.

In numerous key markets, the company consistently rating among most hated in the world is taking major hits.
In India, Monsanto’s illegal introduction of GM Bt cotton is reaping some serious karma. The Ministry of Agriculture has accused Monsanto of price gouging and is reducing their ‘royalties’ by 70 percent. Monsanto has threatened to withdraw its GM crops from India, but the country hasn’t balked. Their reply? “Monsanto is welcome to leave.” Full story...

Related posts:
  1. Indian farmers cotton on to new seed, in blow to Monsanto...
  2. Why is Monsanto miffed at the Indian government?
  3. Are you putting Monsanto in your vagina?
  4. France bans sale of Monsanto herbicide Roundup in nurseries...
  5. Colombia's first steps of resistance against Monsanto's chemical war...

No comments:

Post a Comment